{{Rsnum
|rsid=6967385
|Gene=VWDE
|Chromosome=7
|position=12351693
|Orientation=plus
|GMAF=0.393
|Gene_s=VWDE
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 31.5 | 49.5 | 18.9
| HCB | 17.3 | 46.6 | 36.1
| JPT | 16.1 | 47.3 | 36.6
| YRI | 0.0 | 6.8 | 93.2
| ASW | 0.0 | 24.6 | 75.4
| CHB | 17.3 | 46.6 | 36.1
| CHD | 15.7 | 48.1 | 36.1
| GIH | 25.3 | 45.5 | 29.3
| LWK | 0.0 | 5.5 | 94.5
| MEX | 0.0 | 0.0 | 0.0
| MKK | 2.6 | 25.0 | 72.4
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (placlitaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=6E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}